Celltrion Healthcare Past Earnings Performance
Past criteria checks 2/6
Celltrion Healthcare has been growing earnings at an average annual rate of 17.4%, while the Healthcare industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 19.2% per year. Celltrion Healthcare's return on equity is 2.1%, and it has net margins of 1.9%.
Key information
17.4%
Earnings growth rate
17.4%
EPS growth rate
| Healthcare Industry Growth | 34.2% |
| Revenue growth rate | 19.2% |
| Return on equity | 2.1% |
| Net Margin | 1.9% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Celltrion Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 2,218,023 | 43,133 | 391,901 | 27,636 |
| 30 Jun 23 | 2,066,847 | 135,951 | 368,372 | 25,918 |
| 31 Mar 23 | 2,060,053 | 157,644 | 328,423 | 17,367 |
| 31 Dec 22 | 1,972,188 | 147,178 | 291,722 | 17,750 |
| 30 Sep 22 | 2,036,930 | 237,067 | 252,147 | 13,519 |
| 30 Jun 22 | 1,949,646 | 140,048 | 222,287 | 18,709 |
| 31 Mar 22 | 1,863,891 | 164,644 | 203,177 | 24,428 |
| 31 Dec 21 | 1,804,486 | 152,567 | 192,814 | 29,227 |
| 30 Sep 21 | 1,585,653 | 167,523 | 169,944 | 29,755 |
| 30 Jun 21 | 1,639,954 | 213,010 | 163,150 | 31,618 |
| 31 Mar 21 | 1,626,987 | 195,722 | 153,704 | 33,177 |
| 31 Dec 20 | 1,627,597 | 240,407 | 144,893 | 29,733 |
| 30 Sep 20 | 1,554,163 | 249,216 | 140,999 | 28,353 |
| 30 Jun 20 | 1,372,783 | 173,262 | 126,494 | 24,626 |
| 31 Mar 20 | 1,237,266 | 135,315 | 117,099 | 20,011 |
| 31 Dec 19 | 1,100,878 | 64,962 | 107,409 | 16,684 |
| 30 Sep 19 | 976,014 | -42,023 | 93,449 | 14,486 |
| 30 Jun 19 | 906,649 | -45,782 | 89,395 | 14,479 |
| 31 Mar 19 | 805,635 | -43,278 | 86,147 | 13,953 |
| 31 Dec 18 | 713,487 | 11,386 | 79,258 | 13,505 |
| 30 Sep 18 | 989,193 | 175,707 | 73,933 | 14,263 |
| 30 Jun 18 | 945,767 | 178,499 | 69,507 | 13,608 |
| 31 Mar 18 | 991,440 | 238,447 | 60,644 | 12,795 |
| 31 Dec 17 | 921,500 | 165,684 | 57,744 | 12,036 |
| 30 Sep 17 | 872,771 | 136,604 | 51,231 | 8,277 |
| 30 Jun 17 | 876,929 | 167,562 | 44,737 | 6,845 |
| 31 Mar 17 | 741,590 | 94,037 | 39,521 | 6,785 |
| 31 Dec 16 | 756,437 | 123,503 | 36,028 | 7,130 |
| 31 Dec 15 | 376,033 | -6,740 | 31,867 | 4,120 |
| 31 Dec 14 | 166,549 | 10,133 | 41,413 | 2,165 |
Quality Earnings: A091990 has high quality earnings.
Growing Profit Margin: A091990's current net profit margins (1.9%) are lower than last year (11.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A091990's earnings have grown by 17.4% per year over the past 5 years.
Accelerating Growth: A091990's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A091990 had negative earnings growth (-81.8%) over the past year, making it difficult to compare to the Healthcare industry average (-3.8%).
Return on Equity
High ROE: A091990's Return on Equity (2.1%) is considered low.